New Autism Treatment Targets Gut Health
New research indicates a critical link between the health of the human gut and cognitive function. Fulton Schools researchers such as Professor Rosa Krajmalnik-Brown are among those showing a new gut microbiome therapy could lead to better treatments for neurodevelopment disorders, including autism. An ASU research team completed a study of 18 children who received Microbiota Transfer Therapy, also known as fecal transplant, which is producing improvements in autism-related symptoms. The study shows the gut-brain connection is real, Krajmalnik-Brown says, and that the new treatment that is providing greater gut microbiota diversity raises hope for long-term improvements in the health of people living with autism.